ask="270.00"
ask_size="4700"
average_daily_volume="58222"
bid="0.85"
bid_size="300"
book_value="0.69"
change="+0.00"
change_from_200_day_moving_average="-0.39"
change_from_50_day_moving_average="-0.07"
change_from_52_week_high="-6.79"
change_From_52_week_low="0.24"
change_in_percent="+0.00%"
close="1.16"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.16"
ebitda="-17.60M"
eps_estimate_current_year="-1.09"
eps_estimate_next_quarter="-0.29"
eps_estimate_next_year="-0.82"
ex_dividend_date="N/A"
float_shares="7095000"
high="1.16"
high_52_weeks="7.95"
last_trade_date="1/6/2017"
last_trade_price="1.16"
last_trade_size="300"
last_trade_time="1:43pm"
low="1.15"
low_52_weeks="0.92"
market_capitalization="19.01M"
moving_average_200_day="1.55"
moving_average_50_day="1.23"
name="Bioblast Pharma Ltd. - Ordinary"
notes="N/A"
one_year_target_price="9.00"
open="1.16"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-25.14%"
percent_change_from_50_day_moving_average="-6.07%"
percent_change_from_52_week_high="-85.41%"
percent_change_from_52_week_low="+26.06%"
previous_close="1.16"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.67"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.57"
stock_exchange="NGM"
symbol="ORPN"
volume="13140"
weeks_range_52="0.92 - 7.95"
